URBANI, GINEVRA
 Distribuzione geografica
Continente #
AS - Asia 93
EU - Europa 90
NA - Nord America 79
AF - Africa 2
SA - Sud America 1
Totale 265
Nazione #
US - Stati Uniti d'America 79
HK - Hong Kong 48
IT - Italia 48
SG - Singapore 33
IE - Irlanda 22
CN - Cina 8
FI - Finlandia 7
DE - Germania 6
KR - Corea 4
AT - Austria 3
CI - Costa d'Avorio 2
UA - Ucraina 2
BR - Brasile 1
EE - Estonia 1
NL - Olanda 1
Totale 265
Città #
Hong Kong 48
Singapore 25
Boardman 20
Dublin 20
Perugia 19
Santa Clara 15
Chandler 12
Florence 4
Helsinki 4
Naples 4
Seoul 4
Lappeenranta 3
Los Angeles 3
Munich 3
Vienna 3
Abidjan 2
Bologna 2
Dallas 2
Irpin 2
Seattle 2
Ashburn 1
Boydton 1
Cascina 1
Ercolano 1
Frankfurt am Main 1
Liberty Lake 1
Philadelphia 1
Qingdao 1
São Paulo 1
Tallinn 1
Zhengzhou 1
Totale 208
Nome #
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH 36
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis 36
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 34
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 31
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling 25
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease 22
Bile acids and bile acid activated receptors in the treatment of Covid-19 17
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease 14
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 13
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis 13
Immunology of bile acids regulated receptors 12
Current Landscape and Evolving Therapies for Primary Biliary Cholangitis 9
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases 7
Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis 6
Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future Developments 6
Totale 281
Categoria #
all - tutte 2.055
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.055


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202384 4 1 0 4 10 12 0 4 46 0 0 3
2023/202493 2 2 2 2 10 2 20 12 19 4 11 7
2024/2025104 6 29 20 25 23 1 0 0 0 0 0 0
Totale 281